Drug development: The modelling challenge.
Alla
A
Katsnelson
D000818:Animals; D014150:Antipsychotic Agents / Q000627:therapeutic use; D003071:Cognition / Q000502:physiology; D003072:Cognition Disorders / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D004195:Disease Models, Animal; D055808:Drug Discovery / Q000379:methods* / Q000592:standards; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D020412:Multifactorial Inheritance / Q000235:genetics; D051381:Rats; D015203:Reproducibility of Results; D012559:Schizophrenia / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology
D014150:Antipsychotic Agents